Paper5115151
Topical chemoprophylaxis for burns: trials of creams containing silver sulphadiazine and trimethoprim.
Lowbury EJ and 3 others. Injury, 1971. Cited by 22 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Topical chemoprophylaxis for burns: trials of creams containing silver sulphadiazine and trimethoprim. Papers, record 5115151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5115151
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Topical chemoprophylaxis for burns: trials of creams containing silver sulphadiazine and trimethoprim.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Infective Agents | Major topic |
| Burns | Major topic |
| Folic Acid Antagonists | Major topic |
| Pyrimidines | Major topic |
| Silver Nitrate | Major topic |
| Sulfadiazine | Major topic |
| Wound Infection | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Child | |
| Child, Preschool | |
| Drug Resistance, Microbial | |
| Humans | |
| Infant | |
| Microbial Sensitivity Tests | |
| Middle Aged | |
| Proteus Infections | |
| Pseudomonas Infections | |
| Staphylococcal Infections | |
| Trimethoprim |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27980916 | Self-Assembled Soft Nanomaterials Via Silver(I)-Coordination: Nanotube, Nanofiber, and Remarkably Enhanced Antibacterial Effect. | Adv Sci (Weinh) | 2015 | https://conductscience.org/library/papers/27980916 | PubMed |
| 22693632 | Nanohybrids of silver particles immobilized on silicate platelet for infected wound healing. | PLoS One | 2012 | https://conductscience.org/library/papers/22693632 | PubMed |
| 15825409 | Mechanism of silver sulfadiazine action on burn wound infections. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/15825409 | PubMed |
| 5000382 | Control of infection with gram-negative bacteria in patients at special risk. | Proc R Soc Med | 1971 | https://conductscience.org/library/papers/5000382 | PubMed |
| 4840432 | Properties of silver sulfadiazine-resistant Enterobacter cloacae. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4840432 | PubMed |
| 3031442 | Antimicrobial resistance of Staphylococcus aureus: genetic basis. | Microbiol Rev | 1987 | https://conductscience.org/library/papers/3031442 | PubMed |
| 814955 | Topical chemoprophylaxis with silver sulphadiazine and silver nitrate chlorhexidine creams: emergence of sulphonamide-resistant Gram-negative bacilli. | Br Med J | 1976 | https://conductscience.org/library/papers/814955 | PubMed |
| 321478 | Drug resistance in relation to use of silver sulphadiazine cream in a burns unit. | J Clin Pathol | 1977 | https://conductscience.org/library/papers/321478 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5115151
GET https://conductscience.org/api/papers/v1/5115151/authors